| DIAGNOSTIC PROCEDURES: PROSTATE - UROLOGICAL |
|---|
| To carry cancer diagnostic procedure details for Urological cancer for the prostate. One occurrence of this group is permitted per Core Diagnostic Procedures. | |
| M/R | Data Set Data Elements |
| M | PRETREATMENT PROSTATE BIOPSY TECHNIQUE TYPE |
| M | BIOPSY ANAESTHETIC TYPE |
| DIAGNOSIS: PROSTATE - UROLOGICAL |
|---|
| To carry the diagnosis details for Urological cancer for the prostate. One occurrence of this group is permitted per Core Diagnosis. | |
| M/R | Data Set Data Elements |
| R | MULTIPARAMETRIC MRI SCAN INDICATOR |
| R | MRI ULTRASOUND FUSION GUIDED BIOPSY INDICATOR |
| R | PROSTATE SPECIFIC ANTIGEN (DIAGNOSIS) |
| CANCER CARE PLAN - UROLOGICAL |
|---|
| To carry cancer care plan details for Urological cancer. One occurrence of this group is permitted per Core Cancer Care Plan. | |
| M/R | Data Set Data Elements |
| R | ESTIMATED GLOMERULAR FILTRATION RATE |
| R | HYDRONEPHROSIS CODE |
| R | S CATEGORY CODE |
| LABORATORY RESULTS - UROLOGICAL |
|---|
| To carry Laboratory Result details for Urological cancer. One occurrence of this group is permitted per Core Laboratory Results. | |
| M/R | Data Set Data Elements |
| R | S CATEGORY (ALPHA FETOPROTEIN) |
| R | S CATEGORY (HUMAN CHORIONIC GONADOTROPIN) |
| R | S CATEGORY (LACTATE DEHYDROGENASE) |
| R | LACTATE DEHYDROGENASE LEVEL (NORMAL UPPER LIMIT) |
| STAGING: TESTICULAR - UROLOGICAL |
|---|
| To carry staging details for Urological cancer for testicular. One occurrence of this group is permitted per Core Site Specific Staging. | |
| M/R | Data Set Data Elements |
| R | STAGE GROUPING (TESTICULAR CANCER) |
| R | EXTENT OF METASTATIC SPREAD Multiple occurrences of this item are permitted |
| R | LUNG METASTASES SUB-STAGE GROUPING |
| TREATMENT: BLADDER CHOICE - UROLOGICAL |
|---|
| One of the following can be provided per Urological Treatment | |
| CHOICE 1 - INTRAVESICAL CHEMOTHERAPY | |
| To carry treatment details for Urological cancer for the bladder. One occurrence of this group is required per Core Treatment if selected as the choice. | |
| M/R | Data Set Data Elements |
| M | INTRAVESICAL CHEMOTHERAPY RECEIVED INDICATOR |
| CHOICE 2 - INTRAVESICAL IMMUNOTHERAPY | |
| To carry treatment details for Urological cancer for the bladder. One occurrence of this group is required per Core Treatment if selected as the choice. | |
| M/R | Data Set Data Elements |
| M | INTRAVESICAL IMMUNOTHERAPY RECEIVED INDICATOR |
| TREATMENT: PROSTATE - UROLOGICAL |
|---|
| To carry cancer treatment details for Urological cancer for the prostate. One occurrence of this group is required per Core Treatment. | |
| M/R | Data Set Data Elements |
| R | PROSTATE NERVE SPARING SURGERY TYPE |
| R | RADICAL PROSTATECTOMY MARGIN STATUS |
